CDX2 as a Prognostic Biomarker in Colon Cancer.

PubWeight™: 0.84^‹?›

🔗 View Article (PMID 27248628)

Published in N Engl J Med on June 02, 2016

Authors

Robert R J Coebergh van den Braak¹, John W M Martens¹, Jan N M Ijzermans¹

Author Affiliations

1: Erasmus University Medical Center, Rotterdam, the Netherlands r.coeberghvdbraak@erasmusmc.nl.

Articles citing this ↘

CDX2 as a Prognostic Biomarker in Colon Cancer. N Engl J Med (2016) 0.75

Articles cited by this ↗

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. N Engl J Med (2016) 8.53